News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,630 Results
Type
Article (88021)
Company Profile (825)
Press Release (781764)
Multimedia
Podcasts (198)
Webinars (28)
Section
Business (233291)
Career Advice (4147)
Deals (39885)
Drug Delivery (151)
Drug Development (91432)
Employer Resources (205)
FDA (18400)
Job Trends (17430)
News (397969)
Policy (39973)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3014)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (149)
Alliances (56982)
ALS (181)
Alzheimer's disease (1797)
Antibody-drug conjugate (ADC) (349)
Approvals (18580)
Artificial intelligence (634)
Autoimmune disease (166)
Automation (39)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (490)
Bladder cancer (164)
Brain cancer (65)
Breast cancer (669)
Cancer (5080)
Cardiovascular disease (451)
Career advice (3572)
Career pathing (41)
CAR-T (307)
CDC (59)
Celiac Disease (2)
Cell therapy (838)
Cervical cancer (38)
Clinical research (77079)
Collaboration (1839)
Company closure (5)
Compensation (1171)
Complete response letters (73)
COVID-19 (2994)
CRISPR (99)
C-suite (879)
Cystic fibrosis (155)
Data (6321)
Decentralized trials (2)
Denatured (73)
Depression (151)
Diabetes (536)
Diagnostics (7239)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (304)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (240)
Earnings (100209)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135163)
Executive appointments (1034)
FDA (21610)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1567)
Gene editing (218)
Generative AI (67)
Gene therapy (678)
GLP-1 (1138)
Government (5447)
Grass and pollen (8)
Guidances (387)
Healthcare (20950)
HIV (63)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (296)
Immuno-oncology (61)
Indications (102)
Infectious disease (3283)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (121)
Intellectual property (250)
Interviews (816)
IPO (17959)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (70)
Kidney cancer (17)
Labor market (94)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (99)
Longevity (16)
Lung cancer (683)
Lymphoma (381)
Machine learning (45)
Management (66)
Manufacturing (864)
MASH (175)
Medical device (15040)
Medtech (15095)
Mergers & acquisitions (22999)
Metabolic disorders (1413)
Multiple sclerosis (165)
NASH (23)
Neurodegenerative disease (357)
Neuropsychiatric disorders (101)
Neuroscience (3131)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5112)
Now hiring (66)
Obesity (686)
Opinion (336)
Ovarian cancer (168)
Pain (216)
Pancreatic cancer (232)
Parkinson's disease (303)
Partnered (39)
Patents (512)
Patient recruitment (492)
Peanut (60)
People (66939)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23819)
Phase 2 (33448)
Phase 3 (25199)
Pipeline (5193)
Policy (339)
Postmarket research (3554)
Preclinical (10694)
Press Release (72)
Prostate cancer (250)
Psychedelics (56)
Radiopharmaceuticals (303)
Rare diseases (921)
Real estate (7440)
Recruiting (80)
Regulatory (29074)
Reports (67)
Research institute (2729)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (84)
Schizophrenia (160)
Series A (261)
Series B (198)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (123)
Vaccines (1151)
Venture capital (97)
Weight loss (473)
Women's health (90)
Worklife (22)
Date
Today (173)
Last 7 days (608)
Last 30 days (2634)
Last 365 days (32916)
2026 (2941)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (91)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51581)
Australia (9060)
California (11615)
Canada (3335)
China (1178)
Colorado (493)
Connecticut (504)
Delaware (351)
Europe (118524)
Florida (1704)
Georgia (374)
Hawaii (4)
Idaho (68)
Illinois (971)
India (70)
Indiana (547)
Iowa (24)
Japan (434)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1462)
Massachusetts (8546)
Michigan (362)
Minnesota (668)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (86)
New Jersey (3121)
New Mexico (33)
New York (3067)
North Carolina (1618)
North Dakota (10)
Northern California (5565)
Ohio (354)
Oklahoma (23)
Oregon (55)
Pennsylvania (2321)
Puerto Rico (23)
Rhode Island (50)
South America (1664)
South Carolina (66)
South Dakota (1)
Southern California (4483)
Tennessee (177)
Texas (1830)
United States (41900)
Utah (350)
Vermont (1)
Virginia (292)
Washington D.C. (88)
Washington State (980)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
There are 870,630 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Climb Bio to Present at Upcoming Investor Conferences - February 5, 2026
February 5, 2026
·
1 min read
Press Releases
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
February 5, 2026
·
1 min read
Press Releases
Zomedica Announces “Fourth Friday at Four” Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline
February 5, 2026
·
7 min read
Press Releases
Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM
February 5, 2026
·
4 min read
Press Releases
Microbix Schedules Release of Results for Q1 Fiscal 2026
February 5, 2026
·
4 min read
Press Releases
PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
February 5, 2026
·
4 min read
Pipeline
Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy
Despite the Phase 1 cull, CEO Vas Narasimhan on Wednesday maintained that Novartis continues to invest in its early-stage pipeline, looking for deals in the “sub-$2-billion range.”
February 5, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
February 5, 2026
·
2 min read
Press Releases
Aicuris Presents Positive Phase 3 Data for Pritelivir in Immunocompromised Patients with Refractory Herpes Simplex Virus at TANDEM
February 5, 2026
·
6 min read
Business
Stem Cell Specialist PrimeGen Takes SPAC Track to Nasdaq
The SPAC agreement values PrimeGen US at $1.5 billion in equity and gives it capital to advance its pre-clinical triple-activated mesenchymal stem cell pipeline into the clinic.
February 5, 2026
·
1 min read
·
Tristan Manalac
1 of 87,063
Next
